Literature DB >> 17157338

Identification of membrane progestin receptors in human breast cancer cell lines and biopsies and their potential involvement in breast cancer.

Gwen E Dressing1, Peter Thomas.   

Abstract

Novel membrane progestin receptors (mPRs) coupled to G proteins recently identified in several species, including humans, are potential intermediaries in rapid, nongenomic progestin actions observed in a wide variety of tissues. Here we demonstrate mPR mRNA and protein expression and specific membrane-associated progestin binding in MCF-7 and SK-BR-3 human breast cancer cells. Interestingly, human mPRalpha mRNA expression was higher in breast tumor biopsies than in normal tissue from the same breast. Recent studies indicate intracellular signaling pathways initiated by the mPRs are broadly similar to those induced during breast cancer growth and development. Taken together these results suggest a potential involvement of mPRs during the development or progression of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157338     DOI: 10.1016/j.steroids.2006.10.006

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  29 in total

1.  Broad tissue expression of membrane progesterone receptor Alpha in normal mice.

Authors:  Shaojin You; Lian Zuo; Vijay Varma
Journal:  J Mol Histol       Date:  2010-05-15       Impact factor: 2.611

Review 2.  Pregnane xenobiotic receptors and membrane progestin receptors: role in neurosteroid-mediated motivated behaviours.

Authors:  C A Frye; C J Koonce; A A Walf
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

Review 3.  Estrogen and progesterone receptors: from molecular structures to clinical targets.

Authors:  Stephan Ellmann; Heinrich Sticht; Falk Thiel; Matthias W Beckmann; Reiner Strick; Pamela L Strissel
Journal:  Cell Mol Life Sci       Date:  2009-03-31       Impact factor: 9.261

4.  The Role of mPRδ and mPRε in Human Glioblastoma Cells: Expression, Hormonal Regulation, and Possible Clinical Outcome.

Authors:  Aylin Del Moral-Morales; Juan Carlos González-Orozco; José Moisés Capetillo-Velázquez; Ana Gabriela Piña-Medina; Ignacio Camacho-Arroyo
Journal:  Horm Cancer       Date:  2020-04       Impact factor: 3.869

Review 5.  Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

Authors:  Viroj Boonyaratanakornkit; Nalo Hamilton; Diana C Márquez-Garbán; Prangwan Pateetin; Eileen M McGowan; Richard J Pietras
Journal:  Mol Cell Endocrinol       Date:  2017-11-14       Impact factor: 4.102

6.  Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.

Authors:  Nathan J Charles; Peter Thomas; Carol A Lange
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

Review 7.  Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions.

Authors:  Peter Thomas
Journal:  Front Neuroendocrinol       Date:  2008-02-01       Impact factor: 8.606

8.  Membrane progestin receptors in the midbrain ventral tegmental area are required for progesterone-facilitated lordosis of rats.

Authors:  Cheryl A Frye; Alicia A Walf; Amy S Kohtz; Yong Zhu
Journal:  Horm Behav       Date:  2013-06-12       Impact factor: 3.587

9.  Comparison between steroid binding to membrane progesterone receptor alpha (mPRalpha) and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRalpha-specific agonists.

Authors:  Jan Kelder; Rita Azevedo; Yefei Pang; Jacob de Vlieg; Jing Dong; Peter Thomas
Journal:  Steroids       Date:  2010-01-22       Impact factor: 2.668

10.  Detecting disease associated modules and prioritizing active genes based on high throughput data.

Authors:  Yu-Qing Qiu; Shihua Zhang; Xiang-Sun Zhang; Luonan Chen
Journal:  BMC Bioinformatics       Date:  2010-01-13       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.